Johnson & Johnson Shares Sold by Hamlin Capital Management

Institutional investor reduces stake in healthcare giant

Mar. 16, 2026 at 11:21am

Got story updates? Submit your updates here. ›

Hamlin Capital Management LLC, an investment firm, reduced its holdings in Johnson & Johnson (NYSE: JNJ) by 0.6% in the third quarter, according to a recent SEC filing. The firm now owns 865,870 shares of the company's stock, valued at $160,550,000 as of the filing.

Why it matters

Johnson & Johnson is one of the world's largest and most prominent healthcare companies, so changes in institutional ownership of its stock can be noteworthy. This sale by Hamlin Capital Management, while relatively small, could signal a shift in investor sentiment around the company.

The details

According to the SEC filing, Hamlin Capital Management sold 5,060 shares of Johnson & Johnson during the third quarter. The firm now owns 865,870 shares, making up about 3.7% of its total investment portfolio. Johnson & Johnson is the 17th largest holding for Hamlin Capital Management.

  • Hamlin Capital Management reduced its Johnson & Johnson stake in the third quarter of 2026.

The players

Hamlin Capital Management LLC

An investment management firm that owns a sizable stake in Johnson & Johnson.

Johnson & Johnson

A multinational healthcare company that develops, manufactures, and markets pharmaceutical, medical device, and consumer health products.

Got photos? Submit your photos here. ›

The takeaway

While the sale by Hamlin Capital Management is relatively small, it could signal a shift in investor sentiment around Johnson & Johnson. As one of the world's largest healthcare companies, changes in institutional ownership of its stock are closely watched by analysts and investors.